Intensive insulin treatment in type 2 diabetes

Diabetes Technology and Therapeutics

Volumn 7, Issue 5, 2005, Pages 818-822

  Charles, M Arthur ^a  

^a Diabetes Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ATORVASTATIN; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; DEATH; DIABETIC DIET; DRUG DOSE REGIMEN; EXERCISE; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; ILLNESS BEHAVIOR; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFE EXPECTANCY; MEDICAL PRACTICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HEALTH PERSONNEL; HUMANS; INSULIN; PATIENT COMPLIANCE; PATIENT EDUCATION;

EID: 27644513907     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.818     Document Type: Conference Paper

References (10)

1. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS: A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005;352:1138-1145.
2. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-1656.
3. Hillier TA, Pedula KL: Complications in young adults with early-onset type 2 diabetes: Losing the relative protection of youth. Diabetes Care 2003;26:2999-3005.
4. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial. Lancet 2004;364:685-696.
5. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN; REVERSAL Investigators: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004;291:1071-1080.
6. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R; Systolic Hypertension in Europe Trial Investigators: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999;340:677-684.
7. Larme AC, Pugh JA: Attitudes of primary care providers toward diabetes: Barriers to guideline implementation. Diabetes Care 1998;21:1391-1396.
8. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C: Clinical inertia in response to inadequate glycemic control: Do specialists differ from primary care physicians? Diabetes Care 2005;28:600-606.
9. Grant RW, Buse JB, Meigs JB; University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team: Quality of diabetes care in U.S. academic medical centers: Low rates of medical regimen change. Diabetes Care 2005;28:337-442.
10. Brown JB, Nichols GA, Perry A: The burden of treatment failure in type 2 diabetes. Diabetes Care 2004;27:1535-1540.